"My lab integrates PET imaging and clinical data with fluid markers and post-mortem pathology to identify and validate early diagnostic and prognostic markers that can inform the design of new disease-modifying treatment strategies." Maura Malpetti
UK DRI Emerging Leader
Dr Maura Malpetti is a UK DRI Emerging Leader, a Race Against Dementia Alzheimer’s Research UK Fellow and a Senior Research Associate in the Department of Clinical Neurosciences at the University of Cambridge. She originally trained in Italy for her BSc and MSc, and obtained her PhD in Clinical Neurosciences at the University of Cambridge. She further trained as a visiting researcher at the University of California San Francisco, and the Ludwig Maximilian University of Munich. Her research focusses on in vivo biomarkers for inflammation, tau and synaptic loss to investigate the pathophysiology of primary tauopathies, frontotemporal dementia, and related disorders. To this end, her lab integrates PET imaging and clinical data with fluid markers and post-mortem pathology to identify and validate early diagnostic and prognostic markers that can inform the design of new disease-modifying treatment strategies.
1. Links
Twitter/X: @M_Malpetti
